Загрузка...
Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade
Glucagon receptor (GcgR) blockade has been proposed as an alternative to insulin monotherapy for treating type 1 diabetes since deletion or inhibition of GcgRs corrects hyperglycemia in models of diabetes. The factors regulating glycemia in a setting devoid of insulin and glucagon function remain un...
Сохранить в:
| Опубликовано в: : | Diabetes |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Diabetes Association
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482080/ https://ncbi.nlm.nih.gov/pubmed/28487437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db16-1303 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|